HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.

AbstractBACKGROUND:
Lipoatrophic diabetes is an insulin resistance syndrome characterized by the complete or partial lack of adipose tissue and disturbances in lipid and glucose metabolism. Nonalcoholic steatohepatitis (NASH) is a well-described change in liver pathology consisting of steatosis, hepatitis, and fibrosis that can be associated with lipoatrophic diabetes.
RESULTS:
This article describes the first reported case of lipoatrophic diabetes with NASH leading to liver failure and liver transplantation. Before transplantation, the patient required 600-700 U of insulin/day. After transplantation, a dramatic decline in her insulin requirements was observed, despite corticosteroids. Eighteen months after transplantation, her glycemic control worsened, and she developed recurrent NASH on serial liver biopsies.
CONCLUSIONS:
NASH associated with lipoatrophic diabetes can recur after liver transplantation, and in this case, was accompanied by increased insulin requirements. These results suggest that the development of NASH itself may contribute to the insulin resistance observed in lipoatrophic diabetes.
AuthorsM S Cauble, R Gilroy, M F Sorrell, M E Mailliard, D L Sudan, J C Anderson, J L Wisecarver, S Balakrishnan, J L Larsen
JournalTransplantation (Transplantation) Vol. 71 Issue 7 Pg. 892-5 (Apr 15 2001) ISSN: 0041-1337 [Print] United States
PMID11349722 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Adult
  • Diabetes Mellitus, Lipoatrophic (etiology, physiopathology)
  • Fatty Liver (complications)
  • Female
  • Hepatitis (complications)
  • Humans
  • Insulin Resistance
  • Liver (pathology)
  • Liver Cirrhosis (etiology, pathology)
  • Liver Failure (etiology, surgery)
  • Liver Transplantation
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: